Literature DB >> 22768423

Ca2+ imaging in perfused adrenal medullae.

Akira Warashina1, Masumi Inoue.   

Abstract

The Ca2+ imaging method was developed to explore changes in excitability in adrenal medullary (AM) cells in a large field in response to synaptic input and chemicals. The adrenal medullae of rats and guinea pigs were retrogradely loaded with Ca2+ indicator through the adrenal vein. Nerve fibers remaining in the adrenal gland were electrically stimulated to induce postsynaptic responses in AM cells, and chemicals were applied to the cells by adding to the perfusate. With this method, gamma-aminobutyric acid (GABA) was shown to increase the Ca2+ signal in almost all and 40% AM cells in guinea pigs and rats, respectively.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22768423     DOI: 10.7888/juoeh.34.163

Source DB:  PubMed          Journal:  J UOEH        ISSN: 0387-821X


  4 in total

1.  Identification of muscarinic receptor subtypes involved in catecholamine secretion in adrenal medullary chromaffin cells by genetic deletion.

Authors:  Keita Harada; Hidetada Matsuoka; Hironori Miyata; Minoru Matsui; Masumi Inoue
Journal:  Br J Pharmacol       Date:  2015-01-08       Impact factor: 8.739

2.  Mechanisms and roles of muscarinic activation in guinea-pig adrenal medullary cells.

Authors:  Masumi Inoue; Keita Harada; Hidetada Matsuoka; Jun Nakamura; Akira Warashina
Journal:  Am J Physiol Cell Physiol       Date:  2012-06-27       Impact factor: 4.249

Review 3.  Muscarinic receptors in adrenal chromaffin cells: physiological role and regulation of ion channels.

Authors:  Masumi Inoue; Hidetada Matsuoka; Keita Harada; Lung-Sen Kao
Journal:  Pflugers Arch       Date:  2017-07-31       Impact factor: 3.657

Review 4.  GABA Signaling and Neuroactive Steroids in Adrenal Medullary Chromaffin Cells.

Authors:  Keita Harada; Hidetada Matsuoka; Hiroaki Fujihara; Yoichi Ueta; Yuchio Yanagawa; Masumi Inoue
Journal:  Front Cell Neurosci       Date:  2016-04-18       Impact factor: 5.505

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.